Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction

Annals of Pharmacotherapy

Volumn 36, Issue 1, 2002, Pages 67-71

  Fisher, Alexander A ^a   Davis, Michael W ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Metoclopramide; Serotonin syndrome; Sertraline; Venlafaxine

Indexed keywords

METOCLOPRAMIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; AGITATION; ARTICLE; CASE REPORT; CONFUSION; DEPRESSION; DIAPHORESIS; DYSARTHRIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; HUMAN; HYPERTENSION; MOTOR DYSFUNCTION; NAUSEA; PRIORITY JOURNAL; SEROTONIN SYNDROME; TACHYCARDIA; TACHYPNEA;

ACCIDENTAL FALLS; ADULT; AGED; BASAL GANGLIA DISEASES; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DOPAMINE ANTAGONISTS; DRUG INTERACTIONS; FEMALE; HUMANS; METOCLOPRAMIDE; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIBIAL FRACTURES;

EID: 0036140588     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A161     Document Type: Article

References (24)

1. Fluoxetine and extrapyramidal side effects
2. Movement disorders associated with the serotonin selective reuptake inhibitors
3. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors
4. Selective serotonin-reuptake inhibitor-induced movement disorders
5. Fluoxetine and extrapyramidal symptoms in CNS lupus
6. Mandibular dystonia associated with the combination of sertraline and metoclopramide
7. Serotonin syndrome secondary to the use of sertraline and metoclopramide
8. Mandibular dystonia with Zoloft and Maxalon
9. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders
10. Selection of drugs to treat gastro-oesophageal reflux disease: The role of drug interactions
11. Neuroleptic malignant syndrome associated with metoclopramide
12. Serotonin syndrome. A clinical update
13. The serotonin syndrome
14. Toxic serotonin syndrome or extrapyramidal side-effects?
15. Serotonin syndrome: History and risk
16. Seizure activity and enzyme elevations after venlafaxine overdose
17. Serotonin syndrome following low-dose sertraline
18. Isolated venlafaxine-induced serotonin syndrome
19. A method for estimating the probability of adverse drug reactions
20. Akathisia, suicidality, and fluoxetine
21. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis
22. Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism
23. Regulation of plasma aldosterone levels by metoclopramide: A reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism
24. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography